SCHEMBL11299454

SCHEMBL11299454

CC1(N(c2ccc(Cl)cc2)c2ccc(C(=O)NO)cc2)CCNC1=O

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 14/20 0.44
▸ HDAC6 Q9UBN7 12/20 0.44
▸ HDAC8 Q9BY41 8/20 0.44
▸ ALDH1A1 P00352 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ FLT1 P17948 1/20 0.39
▸ FLT4 P35916 1/20 0.39
▸ KDR P35968 1/20 0.39
▸ HDAC2 Q92769 2/20 0.38
▸ PSEN1 P49768 1/20 0.37
▸ PSEN2 P49810 1/20 0.37
▸ APH1B Q8WW43 1/20 0.37
▸ NCSTN Q92542 1/20 0.37
▸ APH1A Q96BI3 1/20 0.37
▸ PSENEN Q9NZ42 1/20 0.37
▸ HDAC3 O15379 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11297379 0.90 HDAC1 (0.42) HDAC1HDAC6HDAC8HDAC2HDAC3
SCHEMBL11304432 0.89 HDAC6 (0.40) HDAC1HDAC6HDAC8HDAC2HDAC3
SCHEMBL11296090 0.83 HDAC6 (0.41) HDAC1HDAC6HDAC8HDAC2HDAC3
SCHEMBL11294915 0.81 HDAC6 (0.50) HDAC1HDAC6HDAC8ALDH1A1POLB
SCHEMBL11298764 0.80 HDAC1 (0.46) HDAC1HDAC6HDAC8ALDH1A1KDR
SCHEMBL11294786 0.78 HDAC6 (0.46) HDAC1HDAC6HDAC8TDP1KDR
SCHEMBL202512 0.70 HDAC1 (0.65) HDAC1HDAC6HDAC8ALDH1A1FLT1
SCHEMBL11301754 0.69 PSEN1 (0.42) HDAC1HDAC6HDAC8ALDH1A1POLB
SCHEMBL11298688 0.68 HDAC8 (0.42) HDAC1HDAC6HDAC8ALDH1A1POLB
SCHEMBL11303497 0.67 HDAC8 (0.46) HDAC1HDAC6HDAC8ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback